AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TAT Technologies Ltd.

Foreign Filer Report Nov 30, 2022

7072_rns_2022-11-30_c2a05842-a98c-4092-96ce-987b10f84c67.pdf

Foreign Filer Report

Open in Viewer

Opens in native device viewer

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

F O R M 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2022

TAT TECHNOLOGIES LTD.

(Name of Registrant)

Giborei Israel 7, Netanya 4250407, Israel (Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-FForm 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

YesNo

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____________

TAT Technologies Reports Third Quarter 2022 Results

GEDERA, Israel, November 30, 2022 - TAT Technologies Ltd. (NASDAQ: TATT - News) ("TAT" or the "Company"), a leading provider of products and services to the commercial and military aerospace and ground defense industries, reported today its unaudited results for the three months and nine months periods ended September 30, 2022.

Key Financial Highlights:

  • Revenues for Q3 2022 were \$20.9 million compared with \$17.6 million in Q3 2021, an increase of 19%. Revenues for the nine-month period that ended on September 30, 2022 were \$61.7 million compared with \$57.6 million in the nine-month period that ended on September 30, 2021, an increase of 7%.
  • Gross profit for Q3 2022 was \$3.4 million (16.4% as a percentage of revenues) an increase of 16.4% compared with \$3 million (16.8% as a percentage of revenues) in Q3 2021. Gross profit for the nine-month period that ended on September 30, 2022, was \$10.5 million (17% as a percentage of revenues) an increase of 10.6% compared with \$9.5 million (16.5% as a percentage of revenues) in the nine-month period that ended on September 30, 2021.
  • Adjusted EBITDA for Q3 2022 decreased to \$0.6 million compared with \$1 million in Q3 2021. Adjusted EBITDA for the nine-month period that ended on September 30, 2022, was \$2 million compared with \$3.1 million in the nine-month period that ended on September 30, 2021.
  • During the nine months of 2021 the Company received grants (which were recorded as a decrease of expenses) in an aggregate amount of \$4.5 million. Adjusted EBITDA excluding grants increased from a loss of \$1.4 million in the nine-month period that ended on September 30, 2021 to a profit of \$2 million in the nine month period that ended on September 30, 2022. During Q3/21 the company received grants in an aggregate amount of \$2.6 million. Adjusted EBITDA excluding grants increased from a loss of \$1.6 million in Q3/21 compared with a profit of \$0.6 million in Q3/22 (for more details see the proforma comparison below).
  • Net loss continues to decrease and was \$0.35 million, or a loss of \$0.04 per diluted share in Q3 2022 compared with a net loss of \$0.97 million, or \$0.11 per diluted share in Q3 2021. Net loss was \$2 million (out of which \$1.6 million in restructuring costs), or a loss of \$0.23 per diluted share in the nine-month period that ended on September 30, 2022, compared with a net loss of \$2.86 million, or a loss of \$0.32 per diluted share in the nine-month period that ended on September 30, 2021.

Proforma results comparison, representing 2021 without grants:

Thousands USD Q3\22 Q3\21 YTD 22 YTD 21
Revenues 20,977 17,619 61,707 57,564
COGS 17,543 16,747 51,195 51,738
Gross Profit 3,434 872 10,512 5,826
GM 16.4% 4.9% 17 % 10.1%
R&D & SG&M 3,942 4,099 13,437 13,735
EBITDA 559 (1,557) 1,952 (1,488)

3

Mr. Igal Zamir, TAT's CEO and President commented on the results: "The financial results of the third quarter of 2022 represent a continuous improvement in our results compared to the same period in 2021 and reflects the positive trend in our industry going out of the COVID19 pandemic. We continue to make enormous efforts to meet our customers' needs at a time when demand post the COVID-19 pandemic is picking up, but materials and components availability is still problematic". Mr. Zamir continued: "During this quarter we signed a long-term agreement with RTX for the repair of heat components on the Boeing 777 platform. This agreement already generates revenues and will be a contributor to our growth in the coming years. We continue to work on other opportunities that may result from the strategic agreements that we signed with Honeywell last year and we expect positive results in the coming few months".

Non-GAAP Financial Measures

To supplement the consolidated financial statements presented in accordance with GAAP, the Company also presents Adjusted EBITDA. The adjustments to the Company's GAAP results are made with the intent of providing both management and investors a more complete understanding of the Company's underlying operational results, trends and performance. Adjusted EBITDA is calculated as net income excluding the impact of: the Company's share in results of affiliated companies, share-based compensation, taxes on income, discontinued operation, financial (expenses) income, net, depreciation and amortization. Adjusted EBITDA, however, should not be considered as alternative to net income and operating income for the period and may not be indicative of the historic operating results of the Company; nor it is meant to be predictive of potential future results. Adjusted EBITDA is not measure of financial performance under generally accepted accounting principles and may not be comparable to other similarly titled measures for other companies. See reconciliation of Adjusted EBITDA in pages 13 below.

About TAT Technologies LTD

TAT Technologies Ltd. is a leading provider of services and products to the commercial and military aerospace and ground defense industries. TAT operates under four segments: (i) Original equipment manufacturing ("OEM") of heat transfer solutions and aviation accessories through its Gedera facility; (ii) MRO services for heat transfer components and OEM of heat transfer solutions through its Limco subsidiary; (iii) MRO services for aviation components through its Piedmont subsidiary; and (iv) Overhaul and coating of jet engine components through its Turbochrome subsidiary. TAT controlling shareholders is the FIMI Private Equity Fund.

TAT's activities in the area of OEM of heat transfer solutions and aviation accessories primarily include the design, development and manufacture of (i) broad range of heat transfer solutions, such as pre-coolers heat exchangers and oil/fuel hydraulic heat exchangers, used in mechanical and electronic systems on board commercial, military and business aircraft; (ii) environmental control and power electronics cooling systems installed on board aircraft in and ground applications; and (iii) a variety of other mechanical aircraft accessories and systems such as pumps, valves, and turbine power units.

TAT's activities in the area of MRO Services for heat transfer components and OEM of heat transfer solutions primarily include the MRO of heat transfer components and to a lesser extent, the manufacturing of certain heat transfer solutions. TAT's Limco subsidiary operates an FAA-certified repair station, which provides heat transfer MRO services for airlines, air cargo carriers, maintenance service centers and the military.

TAT's activities in the area of MRO services for aviation components include the MRO of APUs, landing gears and other aircraft components. TAT's Piedmont subsidiary operates an FAAcertified repair station, which provides aircraft component MRO services for airlines, air cargo carriers, maintenance service centers and the military.

TAT's activities in the area of overhaul and coating of jet engine components includes the overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes and afterburner flaps.

For more information of TAT Technologies Ltd., please visit our web-site: www.tat-technologies.com

Contact:

Mr. Ehud Ben-Yair Chief Financial Officer Tel: 972-8-862-8503 [email protected]

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements which include, without limitation, statements regarding possible or assumed future operation results. These statements are hereby identified as "forward-looking statements" for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause our results to differ materially from management's current expectations. Actual results and performance can also be influenced by other risks that we face in running our operations including, but are not limited to, general business conditions in the airline industry, changes in demand for our services and products, the timing and amount or cancellation of orders, the price and continuity of supply of component parts used in our operations, the change of control that will occur on the sale by the receiver of the Company's shares held by our previously controlling stockholders, and other risks detailed from time to time in the Company's filings with the Securities Exchange Commission, including, its annual report on form 20-F and its periodic reports on form 6-K. These documents contain and identify other important factors that could cause actual results to differ materially from those contained in our projections or forward-looking statements. Stockholders and other readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. We undertake no obligation to update publicly or revise any forward-looking statement.

5

CONDENSED CONSOLIDATED BALANCE SHEET

(In thousands)

September 30,
2022
December 31,
2021
(unaudited) (audited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents \$
7,311
\$
12,872
Accounts receivable, net 13,368 13,887
Inventory, net 47,601 41,003
Other current assets and prepaid expenses 5,232 4,219
Total current assets 73,512 71,981
NON-CURRENT ASSETS:
Restricted deposit 323 343
Investment in affiliates 1,606 695
Funds in respect of employee rights upon retirement 809 1,157
Deferred income taxes 1,380 1,252
Intangible assets, net 1,675 1,829
Property, plant and equipment, net 39,760 30,462
Operating lease right of use assets 2,833 3,114
Total non-current assets 48,386 38,852
Total assets \$
121,898
\$
110,833
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Current maturities of long-term loans 1,788 \$
691
Credit line from bank 6,061 6,008
Accounts payable 8,579 9,093
Accrued expenses 7,489 6,959
Operating lease liabilities 878 1,169
Provision for restructuring plan 200 657
Total current liabilities 24,995 24,577
NON CURRENT LIABILITIES:
Long-term loans 18,828 5,979
Liability in respect of employee rights upon retirement 1,187 1,504
Operating lease liabilities 1,908 1,989
Total non-current liabilities 21,923 9,472
Total liabilities \$
46,918
\$
34,049
EQUITY:
Share capital 2,843 2,809
Additional paid-in capital 66,194 65,871
Treasury stock at cost (2,088) (2,088)
Accumulated other comprehensive income (81) 33
Retained earnings 8,112 10,159
Total shareholders' equity 74,980 76,784
Total liabilities and shareholders' equity \$
121,898
\$
110,833

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except share and per share data)

Three months ended
Nine months ended
Year ended
September 30, December 31,
2022 2021 2022 2021 2021
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
Revenues:
Products \$
5,694
\$ 5,268 \$ 19,157 \$ 18,221 \$ 25,870
Services 15,283 12,351 42,550 39,343 52,103
20,977 17,619 61,707 57,564 77,973
Cost of goods:
Products 4,710 5,226 16,280 16,362 23,761
Services 12,833 9,443 34,915 31,700 42,942
17,543 14,668 51,195 48,062 66,703
Gross Profit 3,434 2,951 10,512 9,502 11,270
Operating expenses:
Research and development, net 197 97 349 368 517
Selling and marketing 1,312 1,330 4,164 3,993 5,147
General and administrative
Other Income
2,463
-
2,043
-
7,341
(90)
5,974
-
8,354
(468)
Restructuring expenses (income) (30) 122 1,673 2,538 1,755
3,942 3,592 13,437 12,873 15,305
Operating loss (508) (641) (2,925) (3,371) (4,035)
Financial income (expenses), net 73 (257) 647 (117) (540)
Income (loss) before taxes on income (tax benefit) (435) (898) (2,278) (3,488) (4,575)
Taxes on income (tax benefit) (44) 73 (107) (198) (662)
Income (loss) before equity investment (391) (971) (2,171) (3,290) (3,913)
Share in results of affiliated companies (loss) 36 (36) 124 (75) (76)
Net income (loss) from continued operation \$
(355)
\$ (1,007) \$ (2,047) \$ (3,365) \$ (3,989)
Net profit (loss) from discontinued operation \$
-
\$ 40 \$ - \$ 503 \$ 427
Net income (loss) \$
(355)
\$ (967) \$ (2,047) \$ (2,862) \$ (3,562)
Basic and diluted income (loss) per share
Net income (loss) per share from continued operation \$
(0.04)
\$ (0.11) \$ (0.23) \$ (0.38) \$ (0.45)
Net loss per share from discontinued operation \$
0
\$ 0 \$ - \$ 0.06 \$ 0.05
Net income (loss) per share \$
(0.04)
\$ (0.11) \$ (0.23) \$ (0.32) \$ (0.4)
Weighted average number of shares outstanding
Basic 8,909,046 8,874,696 8,909,046 8,874,696 8,874,696
Diluted 8,909,046 8,874,696 8,909,046 8,874,696 8,874,696
7

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

Three months ended Nine months ended Year ended
September 30, December 31,
2022 2021 2022 2021 2021
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
Net income (loss) \$ (355) \$ (967) \$ (2,047) \$ (2,862) \$ (3,562)
Other comprehensive income
Net unrealized income (loss) from derivatives 34 21 (114) (107) (76)
Reclassification adjustments for gains (losses) included in net income
and inventory - - - - (19)
Total other comprehensive income (loss) \$ (321) \$ (946) \$ (2,161) \$ (2,969) \$ (3,657)
8

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands, except share data)

TAT Technologies Ltd. Shareholders
Share capital Accumulated
Number of
shares issued
Amount Additional paid
in capital
other
comprehensive
income (loss)
Treasury
shares
Retained
earnings
Total equity
BALANCE AT DECEMBER
31, 2019
9,149,169 \$ 2,809 \$ 65,573 \$ 26 \$ (2,088) \$ 19,050 \$
85,370
CHANGES DURING THE
YEAR ENDED DECEMBER
31, 2020:
Comprehensive income (loss) - - - 102 - (5,329) (5,227)
Share based compensation - - 138 - - - 138
BALANCE AT
DECEMBER 31, 2020 9,149,169 \$ 2,809 \$ 65,711 \$ 128 \$ (2,088) \$ 13,721 \$
80,281
CHANGES DURING THE
YEAR ENDED DECEMBER
31, 2021:
Comprehensive loss - - - (95) - (3,562) (3,657)
Share based compensation - - 160 - - - 160
BALANCE AT
DECEMBER 31, 2021
9,149,169 \$ 2,809 \$ 65,871 \$ 33 \$ (2,088) \$ 10,159 \$
76,784
CHANGES DURING THE
PERIOD ENDED
SEPTEMBER 30, 2022
(unaudited):
Comprehensive loss - - - (114) - (2,047) (2,161)
Exercise of option 34,450 34 156 - - - 190
Share based compensation - - 167 - - - 167
BALANCE AT
SEPTEMBER 30, 2022
(unaudited)
9,183,619 \$ 2,843 \$ 66,194 \$ (81) \$ (2,088) 8,112 \$
74,980
9

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)

Three months ended
Nine months ended
Year ended
September 30, December 31,
2022 2021 2022 2021 2021
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) \$ (355) \$ (967) \$ (2,047) \$ (2,862) \$
(3,989)
Adjustments to reconcile net income (loss) to net cash provided by
operating activities:
Depreciation and amortization 931 1,440 2,830 3,577 4,881
Loss (gain) from change in fair value of derivatives (7) (21) 1 (46) (19)
Provision for doubtful accounts - 7 (45) 49 248
Share in results of equity investment of affiliated Company (36) 36 (124) 75 76
Share based compensation 56 47 167 105 160
Non cash finance expense (4) (13) (91) (407) (65)
Lease modification (1,315)
Increase (decrease) in provision for restructuring expenses (914) - (457) 470 657
Liability in respect of employee rights upon retirement 9 (59) (317) (49) 94
Impairment of fixed assets - - - 1,800 1,820
Capital gain from sale of fixed assets - - (90) - (468)
Deferred income taxes, net (47) 104 (128) (176) (686)
Government loan forgiveness - - - (1,442) (1,442)
Changes in operating assets and liabilities:
Decrease (increase) in trade accounts receivable 1,127 1,733 (219) (1,693) (2,934)
Decrease (increase) in other current assets and prepaid expenses (557) 1,161 (672) (1,177) (959)
Decrease (increase) in inventory (3,485) (1,634) (6,711) (185) (681)
Increase (decrease) in trade accounts payable (182) (1,303) (1,073) 191 2,571
Increase (decrease) in accrued expenses 499 (836) 531 (532) (218)
Decrease in other long-term liabilities (160) (73) (1,045) (39) 8
Net cash used in operating activities \$ (3,125) \$ (418) \$ (9,490) \$ (2,773) \$
(2,269)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of property and equipment - - 93 - 1,163
Purchase of property and equipment (3,833) (4,652) (11,418) (13,275) (16,247)
Purchase of intangible assets - (11) - (555) (555)
Cash flows used in investing activities \$ (3,833) \$ (4,663) \$ (11,325) \$ (13,830) \$
(15,639)
CASH FLOWS FROM FINANCING ACTIVITIES:
Short-term credit received (repayment) from banks 3,000 - - 3,000 3,000
Proceeds from long-term loans received 3,200 - 15,680 3,042 3,042
Loans and credit line repayment to banks (375) - (636) - -
Exercise of options 123 - 190 - -
Cash flows provided by financing activities \$ 5,948 \$ - \$ 15,234 \$ 6,042 \$
6,042
Cash flows from discontinued operations:
Net profit (loss) from discontinued operation \$ - \$ 40 \$ - \$ 503 \$
(1,845)
Net cash provided by operating activities - 88 - (156) 1,998
Net cash provided by (used in) discontinued activities \$ - \$ 128 \$ - \$ 347 \$
153
Net increase (decrease) in cash and cash equivalents (1,010) (4,853) (5,581) (10,285) (11,089)
Cash and cash equivalents at beginning of period 8,644 18,872 13,215 24,304 24,304
Cash and cash equivalents at end of period \$ 7,634 \$ 14,019 \$ 7,634 \$ 14,019 \$
13,215
10

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP) (UNAUDITED)

(In thousands)

Three months ended
September 30,
Nine months ended
September 30,
Year ended
December 31,
2022 2021 2022 2021 2021
Net income (loss) \$ (355) \$ (967) \$ (2,047) \$ (2,862) \$ (3,562)
Adjustments:
Share in results of equity investment of affiliated companies (36) 36 (124) 75 76
Taxes on income (tax benefit) (44) 73 (107) (198) (662)
Financial expenses (income), net (73) 257 (647) 117 540
Depreciation and amortization 1,041 1,495 3,037 3,758 5,420
Restructuring (income) expenses (30) 130 1,673 2,559 1,755
Discontinued operation (income) loss - (40) - (503) (427)
Share based compensation 56 47 167 105 160
Adjusted EBITDA \$ 559 \$ 1,031 \$ 1,952 \$ 3,051 \$ 3,300
11

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TAT TECHNOLOGIES LTD. (Registrant)

By: /s/ Ehud Ben-Yair Ehud Ben-Yair Chief Financial Officer

Date: November 30, 2022

Talk to a Data Expert

Have a question? We'll get back to you promptly.